NEW YORK (GenomeWeb News) - William Rapeport has joined the board of directors at Galapagos. Rapeport is currently CEO at RespiVert and he is an honorary principal research fellow at the UK’s National Heart & Lung Institute at the Imperial College School of Medicine. has joined the board of directors at . Rapeport is currently CEO at and he is an honorary principal research fellow at the at the .
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.